BioXGEM.
KIDFamMap
Home
Example1
Example2
Statistics
Document
Contact US
Diseases
Inhibitor-Anchor Map
Family Anchors
Kinase-Inhibitor Family
Template
Protein
Surface
Ribbon
Inhibitor
ATP Location
Pocket
ATP
NLP
HAP
CLP
SP
Summary of query kinase
Query kinase
EPHA1 (
P21709
)
Kinase group
TK
Number of conformation types
0
Number of structural templates
49 (
Total 59 inhibitors
)
Select
Template
Comformation
Type
No. of
Templates
Representative
Template
Kinase
Group
Representative
Inhibitor
Inhibitor
Type
No. of
Kinases
No. of
Inhibitors
No. of
Diseases
A
20
2H8HA_H8H
(SRC)
TK
Saracatinib
I
91
255
126
A
2H8HA_H8H
(SRC)
TK
Saracatinib
I
91
255
126
91
255
126
A
2GQGA_1N1
(ABL1)
TK
Dasatinib
I
74
32
117
74
32
117
A
3K54A_1N1
(BTK)
TK
Dasatinib
I
56
32
103
56
32
103
A
3OCTA_1N1
(BTK)
TK
Dasatinib
I
56
32
103
56
32
103
A
1QPDA_STU
(LCK)
TK
staurosporine
I
115
76
126
115
76
126
A
1QPJA_STU
(LCK)
TK
staurosporine
I
115
76
126
115
76
126
A
2HZ4A_4ST
(ABL1)
TK
staurosporine
I
159
103
156
159
103
156
A
2OFUA_1N9
(LCK)
TK
2-aminopyrim...
I
55
215
101
55
215
101
A
2F4JA_VX6
(ABL1)
TK
VX-680
I
110
109
134
110
109
134
A
2XYNA_VX6
(ABL2)
TK
VX-680
I
79
101
105
79
101
105
A
1OPLA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
3PJ3A_04L
(BTK)
TK
Imatinib
II
99
113
134
99
113
134
A
2FO0A_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
1QPEA_PP2
(LCK)
TK
AG 1879
I
29
63
51
29
63
51
A
2G2HA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
1WZYA_F29
(MAPK1)
TK
AC1O4W7N
I
27
48
33
27
48
33
A
2HZIA_JIN
(ABL1)
TK
PD180970
I
90
77
120
90
77
120
A
3RI1A_3RH
(FGFR2)
TK
6-o-tolylqui...
I
29
33
72
29
33
72
A
3IKAA_0UN
(EGFR)
TK
2jkk
I
76
120
108
76
120
108
A
3PIYA_585
(BTK)
TK
R-406
I
93
17
123
93
17
123
B
14
2ITZA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
B
2ITZA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITOA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITYA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2VWUA_7X1
(EPHB4)
TK
Chlorobenzod...
I
77
287
111
77
287
111
B
1H00A_FAP
(CDK2)
TK
AC1NAE4F
I
50
94
75
50
94
75
B
2ITQA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2ITUA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2ITWA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
3LW0A_CCX
(IGF1R)
TK
5-vinyl-3-py...
III
53
30
101
53
30
101
B
3EKNA_GS3
(INSR)
TK
pyrrolo[2,3-...
I
90
215
127
90
215
127
B
2VX1A_7X8
(EPHB4)
TK
DB07256
I
19
37
15
19
37
15
B
1OIRA_HDY
(CDK2)
TK
AC1O6YZF
I
51
203
64
51
203
64
B
1H07A_MFP
(CDK2)
TK
AC1NAKJQ
I
90
241
80
90
241
80
B
3F5PA_741
(IGF1R)
TK
3-cyanoquino...
I
60
123
81
60
123
81
D
1
3AQVA_TAK
(PRKAA2)
TK
dorsomorphin
I
12
41
19
D
3AQVA_TAK
(PRKAA2)
TK
dorsomorphin
I
12
41
19
12
41
19
E
14
3Q96A_0NF
(BRAF)
TK
(2s)-N-[3-(2...
II
19
21
35
E
3Q96A_0NF
(BRAF)
TK
(2s)-N-[3-(2...
II
19
21
35
19
21
35
E
3QRIA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
3QRJA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
1UWHA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
1UWJA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
2OG8A_1N8
(LCK)
TK
1N8
II
35
190
69
35
190
69
E
3C7QA_XIN
(KDR)
TK
BIBF1120
I
25
56
50
25
56
50
E
2E2BA_406
(ABL1)
TK
Bafetinib
II
18
200
48
18
200
48
E
2OO8X_RAJ
(TEK)
TK
RAJ
II
16
246
36
16
246
36
E
2OSCA_MUH
(TEK)
TK
2osc
II
17
136
36
17
136
36
E
3BE2A_RAJ
(KDR)
TK
RAJ
II
19
249
47
19
249
47
E
3CS9A_NIL
(ABL1)
TK
Nilotinib
II
19
132
48
19
132
48
E
3EWHA_K11
(KDR)
TK
k11
II
17
27
46
17
27
46
E
3DZQA_IFC
(EPHA3)
TK
Nilotinib
II
9
30
22
9
30
22